NDATOPICALOINTMENT
Approved
Oct 1965
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
5/8 — Partial
CORDRAN (flurandrenolide) by Molecular Devices is corticosteroid hormone receptor agonists [moa]. Approved for corticosteroid [epc]. First approved in 1965.
Drug data last refreshed 10h ago · AI intelligence enriched Yesterday
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CORDRAN (flurandrenolide) is a mid-potency topical corticosteroid ointment approved in 1965 for inflammatory and pruritic dermatological conditions. It works by stabilizing cellular and lysosomal membranes to reduce inflammation, itching, and vasodilation. The drug is absorbed through intact skin and metabolized hepatically before renal excretion.
$0.003BPart D
LOE ApproachingStable
Mature, stable revenue base with modest team size reflects legacy product approaching loss of exclusivity.
Mechanism of Action
Corticosteroid Hormone Receptor Agonists
Pharmacologic Class:
Corticosteroid
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on CORDRAN offers experience managing a mature, legacy dermatology product with stable but declining revenue and high generic competition. This role is best suited for professionals seeking defensive commercial strategy, cost-containment expertise, or market access specialization rather than growth-stage product development.
Brand Manager
Worked on CORDRAN at Molecular Devices? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.